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UK wide Oromucosal Midazolam is used as an emergency treatment in community for
seizures administered by family/carers with the right training. The Joint Epilepsy
Council (JEC) UK which produced the training guidelines disbanded in 2016. 
Purpose – 
Provide standards for basic epilepsy education and rescue medication (Midazolam)
administration.
Methods - 
The Epilepsy Nurses Association (ESNA), The International League against Epilepsy,
British Chapter (ILAE) and the Royal college of Psychiatrists (RCPsych), used the
Delphi process to update guidelines for the administration of oromucosal midazolam
including developing a voluntary on-line test for carers. During 2017 -2019 a facilitator
worked with two ESNA committees to update the existing guidance and another to
develop a question-bank. Both committee outputs were circulated to the ESNA
membership, then ILAE and RCPsych for review. Patient-facing organizations and
charities opinions were solicited. All feedback was assimilated. A private provider was
contracted to deliver the test.  
Results –
A consensus process involving two task and finish groups of 19 people each
compared, reflected, debated and engaged with stakeholders across three stages. The
updated ratified guidelines were circulated nationally. The Delphi process highlighted
many regions and individuals had local assessment tools and procedures in place,
while others (around 50%) had no assessment provision. 278 carers with a 95% pass-
rate and 100% positive feedback have undertaken the online test (10/2020).
Conclusion –
The UK-wide care provision gap in basic epilepsy-training and safe rescue medication
administration is now addressed. A two-yearly update to the guidelines and test is
planned.
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Abstract 
Background – 
UK wide Oromucosal Midazolam is used as an emergency treatment in community for seizures 
administered by family/carers with the right training. The Joint Epilepsy Council (JEC) UK which 
produced the training guidelines disbanded in 2016.  
Purpose –  
Provide standards for basic epilepsy education and rescue medication (Midazolam) administration. 
Methods -  
The Epilepsy Nurses Association (ESNA), The International League against Epilepsy, British Chapter 
(ILAE) and the Royal college of Psychiatrists (RCPsych), used the Delphi process to update guidelines 
for the administration of oromucosal midazolam including developing a voluntary on-line test for 
carers. During 2017 -2019 a facilitator worked with two ESNA committees to update the existing 
guidance and another to develop a question-bank. Both committee outputs were circulated to the 
ESNA membership, then ILAE and RCPsych for review. Patient-facing organizations and charities 
opinions were solicited. All feedback was assimilated. A private provider was contracted to deliver the 
test.   
Results – 
A consensus process involving two task and finish groups of 19 people each compared, reflected, 
debated and engaged with stakeholders across three stages. The updated ratified guidelines were 
circulated nationally. The Delphi process highlighted many regions and individuals had local 
assessment tools and procedures in place, while others (around 50%) had no assessment provision. 
278 carers with a 95% pass-rate and 100% positive feedback have undertaken the online test 
(10/2020). 
Conclusion – 
The UK-wide care provision gap in basic epilepsy-training and safe rescue medication administration 
is now addressed. A two-yearly update to the guidelines and test is planned.  
Key words – rescue medication; Midazolam; community prevention of status; epilepsy safety; basic 
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1. Introduction: 
 
The estimated epilepsy prevalence in the United Kingdom (UK) is around 1%, suggesting that there 
are about 610,000 people with the condition [1]. Approximately 30% will continue to experience 
seizures, which can sometimes be life threatening [2].  An average of twenty-one people per week in 
the UK  are thought to die as a result of a seizure [3], thus making epilepsy about nine times riskier 
than asthma in terms of premature mortality [4]. In addition, people with epilepsy (PWE) tend to die 
younger, which, in the neurological context, makes stroke the only condition with more years of 
potential life lost [3].  
 
Status Epilepticus (SE), is defined as a continual seizure lasting longer than 30 minutes, or multiple 
seizures, without recovery in between, again lasting half hour [5]. SE has a mortality rate of up to 20%, 
as well as significant, often long term, morbidity. SE can be broken down into four stages; premonitory, 
early, established and refractory [6]. There is evidence to suggest that intervention in the premonitory 
stage of SE, especially in the community, could largely prevent progression to other stages [7]. Thus, 
good knowledge and training of carers and family members of PWE at risk of SE in the community 
could significantly reduce mortality, morbidity and resource costs. Central to the mitigation of this risk 
is the use of emergency epilepsy medication. In the UK, it is standard practice to use oromucosal 
midazolam. In recent years, formulations have been developed in prefilled syringes, making 
administration much easier in emergency situations. However, midazolam in the UK is unlicensed for 
this purpose in adults and is a controlled drug, which can create prescribing and administration 
challenges.  The use of midazolam requires bespoke training and governance, which until recently was 
not available in the UK or globally [7].  
 
The use of midazolam by appropriately trained carers at the right time for the right purpose can 
significantly reduce negative outcomes, and ultimately deaths. Historically, The Joint Epilepsy Council 
of the UK and Ireland (JEC), a voluntary body composed of interested stakeholders, such as epilepsy 
charities, the International League against Epilepsy, British Branch (ILAE) and the Epilepsy Nurses 
Association (ESNA), took responsibility to ensure that educational guidance on this complex area was 
available [8]. However, due to funding and resource concerns, it was disbanded in 2015 with its last 
report being in 2012 [8]. Since then, there has been no clear guidance, standards or pathways to 
ensure safety of the patient, carer or professional, leaving a vacuum in this vital area of epilepsy care 
[7]. This has led to a multifactorial problem (Appendix 1).  
 
ESNA is an UK wide organisation, founded in 1992, with a current membership of 430 nurses with 
competencies in epilepsy care and working professionally with PWE. The majority of the membership 
is involved in basic epilepsy awareness and administration of midazolam training. ESNA, along with its 
affiliates the ILAE and the Royal College of Psychiatrists (RCPsych), sought to develop an up to date, 
nationally evidence based protocol and pathway, to enable best practice for basic epilepsy training 
and midazolam administration, to address the lack of best practice guidance. 
 
2. Methods - 
The project ran from February 2017 to June 2019, from when the update began to the publication of 
the Guidelines [9]. A three-stage Delphi process was utilised identifying from previous similar 
exercises undertaken  specifically in epilepsy (figure 1) [10, 11, 12, 13, 14, 15]. This begins with idea 
generation, followed by an assessment, in this case undertaken by two task and finish group’s made 
up of experienced epilepsy nurses. There then follows feedback and discussion with a wider cohort 
to compare and debate the outcome of the assessment, reflect on the comments made and engage 
with the process prior to reassessment and a final strategy.  
 
2.1 The Delphi Process [10, 11, 12, 13, 14, 15] 
 
The idea generation [11], was begun by the Council of the ILAE, who felt that it was important to 
have robust guidance available for the training of carers in basic epilepsy awareness and midazolam 
administration. They recognised that, in the UK, the remit for such training would normally lie with 
the nursing profession. Additionally, many of the carers requiring such training would be looking 
after the needs of people with intellectual disabilities (ID). Therefore, the ESNA Executive 
Committee, and the Intellectual Disability Faculty of the RC Psych were approached to begin a three-
way dialogue to discuss how best to address this issue. ESNA agreed to lead the initiative, as the 
primary nursing organisation for epilepsy in the UK. It was recognised that there were major regional 
differences in the provision of epilepsy training for carers. There were challenges about the 
availability of suitably qualified trainers, with again a large regional variability. While many epilepsy 
specialist nurses (ESNs) undertake epilepsy awareness and midazolam training as part of their NHS 
role, there are simply too few of them in the UK to provide all of the training required. This has led 
to a proliferation of (mainly) independent training organisations and individuals, with widely varying 
experience and education in epilepsy, filling in the gaps. Serious concerns have been raised about 
the provision and quality of education being provided, and this has been highlighted in a series of 
reports from the learning disabilities mortality review programme (LeDeR), as a major risk factor in 
the premature death of people with epilepsy and intellectual disability in the UK [16]. Variations in 
the expertise of professionals providing services for PWE and ID have been recognised for some 
time, with a recent report continuing to highlight difficulties [17]. Following the dissolution of the 
JEC, a vacuum had been left in the guidance underpinning basic epilepsy training courses. The three 
organisations began to work together to build a fresh consensus regarding the content, level and 
duration of this vital education.  
 
Two parallel task and finish groups, consisting of 19 members, identified by a general call out to the 
ESNA membership, and led by two experts in the field (ST and EC), was set up to assess the 
recommendation to develop training standards. All regions of the UK and different stakeholder 
specialties (Intellectual disability, adult, paediatrics) were represented.   They were mandated to 
form a consensus on the minimum standards of epilepsy training required for paid carers, as well as 
to devise and revise the available learning resources, using the JEC guidelines as a template [8]. The 
outputs of the two groups were subject to an extensive, multi-professional, UK wide consultation, 
utilising stage 2 of the Delphi process, to compare, reflect, debate and engage with stakeholders to 
refine the assessment process [10]. The outcomes from this process were drafted and sent to expert 
practitioners from the ILAE, Royal College Nursing (RCN) and the RCPsych, external from ESNA, for 
peer review as part 3 of the Delphi process. This was supplemented with feedback from patient 
facing organisations such as national charities (SUDEP Action, Epilepsy Society, Epilepsy Action etc.).  
 
During the initial idea generation stage of the Delphi process, importance was attached to the 
assessment of any training provided, in order to ensure uniform quality. Therefore, it was decided 
that a second task and finish group should be established, in parallel to the guideline consultation, to 
explore remote assessment. A UK wide group of epilepsy specialist nurses (ESN’s), from paediatric, 
Intellectual disability and neurology services, were brought together to devise an on-line test in 
order to evaluate carer knowledge of epilepsy following the completion of a local training program.  
A successful pilot project, undertaken in the UK county of Cornwall (pop: 538,000), using the ‘teach 
and test’ model, demonstrated proof of principle and formed the basis of the assessment tools [7]. 
Questions devised and submitted by ESNA members were edited, quality checked and ratified by an 
oversight group of medical practitioners and educationalists assembled by the ILAE. Responsibilities 
for hosting the test and creating a suitable online platform were handed to Virtual College (VC), an 
education organisation with experience in providing on-line education and assessment in the field of 
healthcare [18]. A pilot test was sent for the ESNA membership to try, and adjustments made 
according to the feedback received. The full test was launched in conjunction with the guidelines. It 
is hosted by VC (http://epilepsyassessment.virtual-college.co.uk/). 
 
2.2. Ethics and participation consent 
No ethical permission was sought as no patients were involved. Consent was implicit by participation 
for the clinical practitioners group. All participants were advised at the start of the project that 
contributions were voluntary and their replies, i.e. data, would be anonymised.  The project was 
reviewed by the participating organisations. 
 
3 Results 
Regional differences in the approach to epilepsy training emerged during the Delphi process (table 1). 
Some areas of the UK, most notably Scotland and Cornwall, have very well established procedures to 
deliver effective epilepsy awareness and midazolam courses to care staff. However, these 
arrangements only cover around 10% of the UK by population.   
 
Initial discussions proposed that all training should be undertaken by qualified nurses or doctors. 
This was amended to state that trainers without a nursing or medical qualification or nurses/doctors, 
who have no epilepsy experience in the last two years, must have attended a train the trainer 
course. There are additional safeguards to allow for deviation from the guidelines, provided there 
are clear lines of accountability set in place locally. Changes made to the previous JEC guidelines 
have been clearly highlighted in the new document [9]. 
 
The duration of the training courses was scrutinised during all stages of the Delphi process. The JEC 
guidelines [8] mandated that epilepsy awareness and midazolam training combined should last 
between four and six hours. Task and finish group members were concerned that this may be too 
long to allow care organisations to release staff to attend courses. However, the aim of the 
educational guidelines and associated assessment, was to provide carers with an adequate 
knowledge of epilepsy to enable them to act confidently when asked to manage someone having a 
seizure, and to practice the technique for administering midazolam. It was also recognised that 
these are best practice guidelines, so to recommend a shorter course, which by definition would 
require content to be omitted, was contrary to the project brief. Indeed, the task and finish groups 
identified topics missing from the last iteration of the JEC guidelines [8], which they felt were 
essential, for example sudden unexpected death in epilepsy (SUDEP). 
 
There was broad agreement in the multi-agency consultation with the content of the training courses, 
but disagreement about which elements should be essential, and which desirable. Following extensive 
consultation, all elements of the midazolam training were considered to be essential, while flexibility 
was allowed with regard to content of epilepsy awareness courses. Allowance was also made for 
bespoke training, tailored to the needs of a particular individual [9], providing the care and training 
organisations had clear lines of accountability, justifying deviation from best practice. An example 
might be a school setting with only one child who has epilepsy. Bespoke training for the staff in that 
situation could be delivered in a shorter timeframe, as they would need to respond to an individual’s 
needs, rather than having to address the varying needs of a cohort of people. The key points of the 
guidelines are set out in appendix 2 and the final published guidelines available freely from 
www.ESNA-online.org.  The list of participants in the different Delphi stages and their professional 
roles is provided in table 2.  
During the Delphi process, it became apparent that many regions and individuals had local 
assessment tools and procedures in place, while others (around 50%) had no assessment provision. 
A need to establish a national, minimum assessment was agreed, with local assessments taking place 
alongside the online test hosted by VC [9, 18].  
 
The Delphi process brought the following key elements of the on-line assessment into focus: the 
need for the test to comprise three broad sections: epilepsy awareness, safety and seizure 
treatment, first aid and emergency medication administration. Pass rates were set at 80%, 100% and 
100% respectively. Candidates needed to pass each section in order to progress to the next level. A 
bank of 110 questions was produced from members’ submitted questions. This meant that anyone 
re-taking the test would not have the same questions the second time, and that delegates on the 
same course would also, largely, have different questions to their colleagues. Example questions are 
provided in table 3. 
 
By 10/2020, 278 people had attempted the online test. 96% had taken the full test (it is possible to 
choose epilepsy awareness only). The average time to complete the full test was 27 minutes while 
the epilepsy awareness section took 7 minutes. The pass rate pre-set for the full test was 95%, with 
100% pass rate for the epilepsy awareness section. Of all assessments 71 are incomplete. Of these, 
10 learners are ‘in progress’ and 61 ‘not started’.   
4. Discussion 
The training of carers for PWE in the UK was fragmented, patchy and inconsistent. The ESNA 
guidelines [9] allow care providers to critically evaluate the content of their training providers. The 
guidelines are freely available from the ESNA website, (www.ESNA-online.org) the ILAE, RCPsych and 
leading epilepsy charities. They were disseminated electronically to all ESNA/ILAE/RCPsych members 
and, via the Epilepsy Action newsletter and Nursing Times [19].  
 
The use of a nationally accredited, standardised test, gives care providers’ confidence that their staff 
have received adequate education to safely manage PWE. Carers are assured that they have 
correctly understood the course and are better prepared to manage seizures. The test is free to avail 
but a £5.00 fee is charged for certification. This allows professional care organizations to ensure their 
employed carers are trained while families and private carers can use the test for knowledge 
updates.  The collected fees go to further question bank update and development.  
 
The challenge is to incorporate these guidelines and the associated on-line test, into routine service 
delivery. Safety is a key component in recent UK policy documents such as NHS Right Care [20] and 
Step Together [21]. While applicable in all care settings, the guidelines will be of most benefit to ID 
services. The Learning Disability Mortality Reviews, which looks into causes of premature mortality 
in people with ID, highlight the disproportionate epilepsy related deaths (5%) and epilepsy as a 
contributory factor (40%), pointing out gaps in training [16]. The guidelines along with other similar 
safety initiatives could improve patient safety [22].  
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Appendix 1- Examples of concerns surrounding the administration of emergency medication for 
PWE7 
Patient concern-The ability of carers to respond appropriately in an emergency especially if the 
patient is unconscious   
Professional carer concerns - When to give the medication, and when/if to withhold it  
Prescriber concerns – A lack of confidence in the competence of carers to administer medication as 
prescribed, a potential to cause iatrogenic harm and lack of regulation clarity. 
  
 
Appendix 2 – Key messages from the ESNA best practice guidelines [8] 
The recommended content for epilepsy awareness and midazolam administration courses 
 
Face to face  training to be delivered by qualified nursing or medical practitioners, with a 
minimum of two years’ experience working with people who have epilepsy, evidence of continued 
professional development (CPD)  and a minimum of one year experience delivering 
training/facilitation courses with a recognised teaching and assessment qualification. 
 
Trainers without a nursing or medical qualification and/or who do not have two years’ experience 
working with people who have epilepsy, must attend a ‘train the trainer’ course, facilitated by a 
practitioner meeting the above requirements. 
 
Initial training should last 4 to 6 hours, with a minimum of two yearly refreshers lasting 2 to 3 
hours (this should be tailored to individual needs and could therefore vary). 
 




Table 1 - Delphi results 
 
Round 1 – scoping meeting Round 2 – ESNA membership 
engagement, comparison, 
reflection and debate 
Round 3 – final outcome9 
Trainer experience and 
competence 
Did this person have to hold a 
medical or nursing 
qualification? What 
experience/qualifications in 
epilepsy, training and 
assessment was required? 
Hold a nursing or medical 
qualification, a recognised 
qualification in teaching and 
assessing, 2 years recent 
experience of working with 
PWE. Trainers without the 
above must have attended a 
train the trainer’s course 
facilitated by a person meeting 
the requirements. 
Duration of courses JEC guidelines recommended 
4-6 hours to teach epilepsy 
awareness and midazolam 
administration to professional 
carers with no prior 
knowledge, with refreshers 
lasting 2-3 hours. Debate 
whether this was too long, 
would prove difficult to 
implement due to staff 
availability to attend and 
therefore increase the risk of 
no education being delivered. 
Not possible to teach required 
epilepsy awareness in less 
time. Unsafe to train 
professional carers with no 
prior knowledge of epilepsy to 
administer midazolam without 
underpinning knowledge of 
epilepsy. Course duration 
recommended to be 4-6 hours 
with 2-3 hour refreshers unless 
bespoke training required for 
an individual, in which case the 
duration could vary depending 
on the complexity of needs. 
Course content Delegates felt that the JEC 
content was still applicable, but 
that there were significant 
omissions (e.g. SUDEP). 
Extensive debate produced a 
list of required topics. 
Significant further debate 
about course content. Decision 
made to have essential and 
desirable elements. For 
example, recognising common 
seizure types was considered 
essential, whereas 
psychosocial aspects of 
epilepsy were desirable. 
Refresher course frequency 
and content 
JEC guidelines recommended a 
refresher course every 2 years. 
Consideration given to 12 
month refreshers. Concerns 
about capacity versus safety. 
Carers should attend a 
refresher course every 2 years. 
Mode of delivery (face to face 
or remote) 
Consensus quickly reached 
about midazolam 
administration, which needed 
to be taught face-to-face due 
to practical administration. 
Considerable debate about 
Final position was that all of the 
course should be taught face-
to-face. This was to be 
reviewed formally as part of 
the guidelines evaluation 
process. 
whether epilepsy awareness 
could be taught remotely. 
Indemnity How to ensure indemnity 
insurance to protect 
practitioners and organisations 
from malpractice claims 
related to training provided. 
Vicarious liability from 
employing organisation, or 
obtained independently. Up to 
date professional development 
(in the UK, this is regulated by 
statutory bodies for nursing 
and medical professionals). 
Following best practice 
teaching guidelines9 
Care plan documentation Important for robust 
documentation outlining when 
emergency intervention is 
required, midazolam dose and 
frequency. Important to make 
an example care plan available 
as part of the guidelines. 
Care plans in use by wider ESNA 
membership considered. 
Commonalities identified and 
draft produced. Final version 
appended with the guidelines9. 
Accountability Lots of interregional variability 
surrounding the delivery of 
epilepsy awareness and 
midazolam training. Concerns 
about professional 
accountability and indemnity if 
full guidelines not followed. No 
resolution at stage 2 and 
question debated by wider 
membership. 
There are some areas of the UK 
with well established 
procedures for delivering 
epilepsy training, but which 
vary from the consensus 
guidelines. The final resolution 
was to outline the training 
organisation’s responsibilities 
and specifically that deviations 
from the recommendations 
made in the guidelines9 must 
have clear lines of 
accountability. 
Assessment content Debate around whether there 
should be a single assessment 
covering all aspects of epilepsy 
awareness and midazolam 
administration, or whether the 
assessment should be divided 
into sections in an incremental 
manner, so that one section 
needs to be passed before the 
next is attempted. The wider 
membership were invited to 
produce relevant questions 
(table 3), which was 
subsequently reviewed in a 
two-stage process by ESNA and 
the ILAE. 
The assessment was divided 
into three sections; epilepsy 
awareness, safety and seizure 
treatment, first aid and 
emergency medication 
administration. Each section 
has to be passed before moving 
onto the next in an incremental 
manner. Pass rates were set at 
80% for epilepsy awareness, 
with 100% for safety and 
seizure treatment. 
Assessment format Many individual assessments 
were evaluated. A consensus 
formed around a single unified 
test to help promote uniform 
Consensus formed around the 
benefits of remote testing with 
audit facilities. Virtual College 
standards. Some debate about 
whether this could be delivered 
face-to-face or by electronic 
means. Remote assessment 
held advantages in terms of 
audit. Promising results from a 
pilot in Cornwall. Debate about 
hosting the assessment. 
(VEC) chosen as host for the 
online test. 
Assessment methods Many methods in use. Written 
tests, with multiple choice or 
longer written answers were 
commonly in use, sometimes 
alongside quizzes, verbal and 
practical assessments. 
Recommendation that all 
course delegates take the 
online test. This can be 
supplemented by local testing 
arrangements, mandated by 
the care organisation and/or 
the training organisation. 
Cost of assessment Delegates felt that the ideal 
would be to provide a free 
online assessment. However, 
this proved impossible to 
achieve in practice with no 
organisations been able to 
provide free technical support 
and hosting. There was 
considerable disagreement 
about whether to mandate a 
purchased test. 
The benefits of providing a 
uniform test with a stable 
platform provided by an 
organisation with considerable 
online health education 
experience and incorporating 
an audit function was felt to 
outweigh the nominal cost of 
£5.00 per test. This was 




Table 2   – Panellists for the Delphi process 
 
Name Title Affiliated organisation 
Phil Tittensor Consultant Nurse, Honorary 
lecturer, Chairperson of ESNA,  
ESNA - project lead for ESNA – 
task and finish group member 
Sarah Tittensor ESN, adult,  ESNA - lead of the on-line 
assessment task and finish 
group 
Erica Chisanga Consultant Nurse, ESNA - lead of the guidelines 
task and finish group 
Marie Hooper ESN, adult ESNA – task and finish group 
member 
Alison Holmes ESN, adult ESNA – task and finish group 
member 
Shelly Brett ESN, adult ESNA – task and finish group 
member 
Marie Synnott-Wells ESN, adult ESNA – task and finish group 
member 
Martain Smith ESN, paediatrics ESNA – task and finish group 
member 
Mary Codling ESN, intellectual disabilities ESNA – task and finish group 
member 
Lynda Morris ESN, adult ESNA – task and finish group 
member 
Jill Conium ESN, adult ESNA – task and finish group 
member 
Hazel Thomas ESN, paediatrics ESNA – task and finish group 
member 
Jackie Scott ESN, adult ESNA – task and finish group 
member 
Mel Goodwin ESN, adult ESNA – task and finish group 
member 
Caryn Jory ESN, intellectual disabilities ESNA – task and finish group 
member 
Fiona Hughes ESN, adult, Chairperson ESNA 
Scottish locality group 
ESNA – task and finish group 
member 
Pam Iddon ESN, adult, epilepsy 
commissioning support 
ESNA – task and finish group 
member 
Lesley Alexander ESN, adult, lead representative 
for Northern Ireland 
ESNA – task and finish group 
member 
Jan Bagshaw Independent epilepsy 
consultant nurse 
ESNA – task and finish group 
member 
Mathew Walker Professor of Neurology, 
Consultant Neurologist, 
President ILAE (Europe) 
ILAE – special advisor 
Manny Bagary Consultant Neuropsychiatrist 
President ILAE (British Chapter) 
ILAE – project lead for ILAE 
Juliet Solomon Director ILAE ILAE – special advisor 
Richard Hills General Practitioner, GP lead 
for ILAE 
ILAE – special advisor 
Ashok Roy Consultant Psychiatrist, RC 
Psych lead for Intellectual 
Disability Faculty 
RC Psych – special advisor 
 
Rohit Shankar Professor of Neuro psychiatry 
Consultant Psychiatrist,  
RC Psych - Medical advisor and 
project lead for RC Psych. 
Jean O’Hara FRC Psych, National clinical 
director for learning 
disabilities, Consultant 
Psychiatrist, Visiting Senior 
Lecturer 
RC Psych – special advisor 
Eileen Joyce Professor of Neuropsychiatry, 
Chair or RCPsych 
neuropsychiatry group 
Consultant Psychiatrist 
RC Psych – special advisor 
Maria Oto Consultant Psychiatrist, 
executive member of RCPsych 
Neuropsychiatry group & ILAE 
British Chapter executive 
member 
RC Psych – special advisor 
Mike Wilcock Pharmacist, head of prescribing 
support unit 
Special advisor 
Reena Tharain Community pharmacist Special advisor 
Dominic Slowie General practitioner, National 
Clinical Advisor (learning 
disability and premature 
mortality) NHS England 
Special advisor 
Epilepsy Action  National Charity  Stakeholder group 
SUDEP Action National Charity  Stakeholder group 
 
  
Table 3 – Example questions from the on-line test 
Epilepsy awareness 
 





















































Yes   No     B 
Safety 
Question A B C D E Correct 
answer/
s 
If you are 
with a person 
who is in the 
bath, what 
should you 
do to help 
them?(select 







Lift them out 
of the bath 
and lay them 
on the floor 









side of the 
bath and over 













in the event 








The length of 
time of the 
seizure 
Descriptio





























If the person 
















Seizure treatment, first aid and emergency medication administration  
 
Ann is a 50 








say it is fine 
to hide her 
medication 
in her food. 
\What do 
you do?  
Agree and 

























the right to 
refuse her  
medication 




not to give 
them 
  B 
What are the 
circumstance
s to call an 
ambulance 
when a 














































Has it been 
stored 
correctly (i.e. 
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